AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24002121
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times daily for 9 months
Trial: 24002121
Drug: Sibutramine 10
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 10 mg daily for 9 months
Trial: 8622077
Drug: Radioimmunoguided surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioimmunoguided surgery (RIGS) using iodine 125‐labeled monoclonal antibodies (MAbs) B72.3 (anti‐TAG72)
Trial: 8622077
Drug: Radioimmunoguided surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioimmunoguided surgery (RIGS) using iodine 125‐labeled monoclonal antibodies (MAbs) FO23C5 (anti‐carcinoembryonic antigen [CEA])
Trial: 3914702
Drug: Piroxicam 20
RxNorm normalized name: piroxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 20 mg/d
Trial: 27087092
Drug: TEST 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEST 500 mg
Trial: 27087092
Drug: REF® 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REF® 500 mg
Trial: 22318492
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral desensitization protocol enabled with omalizumab (anti-IgE monoclonal antibodies)
Trial: 19514438
Drug: PEA with
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEA with intramuscular ketorolac
Trial: 19514438
Drug: PEA with
RxNorm normalized name: Pea
DrugBank: Pea (DB10551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEA with intramuscular ketorolac and intravenous paracetamol
Trial: 11410120
Drug: Oral combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral combined hormone replacement therapy (HRT)
Trial: 18261392
Drug: Anticoagulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulation therapy (Acenocoumarol)
Trial: 12829890
Drug: Tac and
RxNorm normalized name: Nystatin and Triamcinolone Acetonide Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tac and steroids (control)
Trial: 12829890
Drug: TacSRL0.5 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TacSRL0.5 (0.5 mg SRL)
Trial: 12829890
Drug: TacSRL1 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TacSRL1 (1 mg SRL)
Trial: 12829890
Drug: TacSRL2 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TacSRL2 (2 mg SRL)
Trial: 6542402
Drug: Praziquantel (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (40 mg/kg single dose)
Trial: 6542402
Drug: Integrated chemotherapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated chemotherapy, sanitation improvement, and health education
Trial: 6542402
Drug: Control (only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (only chemotherapy)
Trial: 31914451
Drug: Aspirin +
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin + Clopidogrel (ASP-CLO)
Trial: 22900932
Drug: Screening intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Screening intervention (fasting plasma glucose measurement and referral to GP if FPG ≥ 6.1 mmol/L)
Trial: 18937623
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac formulations (sodium lotion, lecithin or epolamine gel, patch or plaster)
Trial: 18937623
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac formulations
Trial: 15769238
Drug: Presentation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presentation of performance information with small numbers (e.g., absence rates of 2% vs. 5%)
Trial: 15769238
Drug: Presentation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presentation of performance information with large numbers (e.g., attendance rates of 98% vs. 95%)
Trial: 10094298
Drug: Multi-sensory stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-sensory stimulation (auditory, tactile, visual, and vestibular intervention) for 15 minutes, twice a day, five days a week, for four weeks during hospitalization
Trial: 7538547
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with zidovudine and L‐697,661
Trial: 7538547
Drug: L‐697,661 alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐697,661 alone
Trial: 6631566
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1 g orally once a day, five times a week for 20 weeks)
Trial: 6631566
Drug: Zinc (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (60 mg as zinc gluconate once a day, five times a week for eight weeks)
Trial: 30316907
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive pill (OCP) - 35μg of ethinylestradiol plus 2mg of cyproterone acetate for 6 cycles (28 days each)
Trial: 30316907
Drug: Metformin -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin - 500mg administered twice daily for 6 months
Trial: 30316907
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (placebo pills during OCP treatment)
Trial: 1927064
Drug: NSAID treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID treatment
Trial: 16849624
Drug: Ziconotide administered
RxNorm normalized name: Ziconotide
DrugBank: Ziconotide (DB06283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ziconotide administered intrathecally via continuous infusion
Trial: 8784096
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment (2 IU/m2 day)
Trial: 1732485
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral administration of a combination of rapid- and slow-release diclofenac (Voltaren)
Trial: 1732485
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intramuscular diclofenac and an oral depot formula
Trial: 6370978
Drug: Nomifensine (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nomifensine (100-150 mg/day)
Trial: 6370978
Drug: Imipramine (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (100-150 mg/day)
Trial: 28513784
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine solution with alcohol
Trial: 28513784
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine solution without alcohol
Trial: 25599737
Drug: Pamidronate (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate (30 mg intravenous infusion within 2 days after transplantation and 3 months later)
Trial: 23163418
Drug: Cabergoline (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (1.25 mg)
Trial: 19145720
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health promotion programme for parents (test group)
Trial: 16257151
Drug: Isoflavone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone (300 mg standardized soy extract with 120 mg isoflavones/day)
Trial: 16257151
Drug: Estrogen (0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen (0.625 mg conjugated equine estrogens + placebo)
Trial: 8865524
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg bid ticlopidine for 4 weeks
Trial: 10221828
Drug: antacid
RxNorm normalized name: Antacid
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: antacid
Trial: 30670280
Drug: Heart rate
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heart rate variability biofeedback 15 min daily for three months
Trial: 19142552
Drug: Target glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target glucose level of 80-130 mg/dl
Trial: 19142552
Drug: Target glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target glucose level of 160-200 mg/dl
Trial: 17292730
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of almonds
Trial: 17292730
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g of almonds
Trial: 17292730
Drug: 90 g
RxNorm normalized name: Fora G90 Glucose Test Strip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 g of almonds
Trial: 15592001
Drug: Mandibular overdentures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular overdentures retained by a bar attachment (combined mucosa-implant-supported overdenture)
Trial: 15592001
Drug: Combined mucosa-implant-supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined mucosa-implant-supported overdentures
Trial: 9538375
Drug: Bepridil (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bepridil (300 mg/day in 3 doses)
Trial: 9538375
Drug: Diltiazem (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (180 mg/day in 3 doses)
Trial: 8370371
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg o.d. for 3 weeks, increased to 100 mg o.d. for final 3 weeks
Trial: 8370371
Drug: Nicorandil 10
RxNorm normalized name: nicorandil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 10 mg b.d. for 3 weeks, increased to 20 mg b.d. for final 3 weeks
Trial: 3092601
Drug: Metamizol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metamizol (2.5 g)
Trial: 24982069
Drug: TOL-TAZ plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TOL-TAZ plus metronidazole (1.5 g TOL-TAZ every 8 hours with 500 mg metronidazole every 8 hours)
Trial: 11054442
Drug: Meropenem (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem (1 g every 8 hours)
Trial: 22561357
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of oral caffeine
Trial: 19886384
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (150 mg) intramuscularly every 2 weeks for 12 weeks
Trial: 15064097
Drug: Micronized fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized fenofibrate (200 mg/day, 6 week treatment)
Trial: 10051462
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) therapy (13-15 mg/kg/d)
Trial: 31021041
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) injection, four sessions with 2 weeks intervals
Trial: 28131654
Drug: Febuxostat (ULORIC®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat (ULORIC® tablet, 80 mg)
Trial: 12632617
Drug: Moderate-dose group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose group (M)
Trial: 12632617
Drug: High-dose group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose group (H)
Trial: 42577
Drug: Oral prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prostaglandin E2
Trial: 1609525
Drug: Preventive massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive massage ointment administration
Trial: 6743779
Drug: Nifedipine capsule
RxNorm normalized name: Nifedipine Capsules
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine capsule (Adalat, Bayer) 10 mg
Trial: 6743779
Drug: Nifedipine tablets
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine tablets (Taro) 10 mg
Trial: 23647409
Drug: Ciprofloxacin 750
RxNorm normalized name: ciprofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 750 mg
Trial: 2940971
Drug: Ciprofloxacin 1
RxNorm normalized name: ciprofloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 1 g
Trial: 2940971
Drug: Ciprofloxacin (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (various doses)
Trial: 2940971
Drug: Ciprofloxacin 750
RxNorm normalized name: ciprofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 750 mg every 12 h
Trial: 24646100
Drug: KTP laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KTP laser therapy (0.8W, time on 50 ms, time off 50 ms, 30 s, 532 nm) followed by SRP
Trial: 22396084
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg intravenous tramadol
Trial: 22396084
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg intravenous tramadol + 330 mg paracetamol
Trial: 20869570
Drug: Placebo matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo matching sprays
Trial: 15671125
Drug: Propranolol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (25 mg)
Trial: 8813039
Drug: Less suppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less suppression of plasma HIV RNA by treatment
Trial: 1603387
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg, twice daily for 5 days)
Trial: 1603387
Drug: Trimethoprim/sulfamethoxazole (TMP/SMX,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim/sulfamethoxazole (TMP/SMX, 160/800 mg, twice daily for 5 days)
Trial: 6399927
Drug: Oral leucine
RxNorm normalized name: Leucine
DrugBank: Leucine (DB00149)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral leucine at a dose of 0.2 g per kg per day
Trial: 6399927
Drug: Oral leucine
RxNorm normalized name: Leucine
DrugBank: Leucine (DB00149)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral leucine
Trial: 30188798
Drug: Transdermal T
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal T gel targeting lower [400‐550 ng/dL] T range
Trial: 30188798
Drug: Transdermal T
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal T gel targeting higher [600‐1000 ng/dL] T range
Trial: 24983989
Drug: Live oral
RxNorm normalized name: Cholera Vaccine Live Oral
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live oral cholera vaccine VA 1.4 (1.9×10^9 CFU)
Trial: 22441135
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy for 8 months in group D (DM (‐), HT (‐))
Trial: 22441135
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy in group A (DM (+), HT (+))
Trial: 22441135
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy in all groups
Trial: 18243335
Drug: All antipsychotic
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All antipsychotic treatments
Trial: 16012274
Drug: Nocturnal intravenous
RxNorm normalized name: Nocdurna
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nocturnal intravenous TRH 500 microg
Trial: 12887812
Drug: Lactulose (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (15 - 90 ml/day) for 8 weeks in Stg
Trial: 12887812
Drug: Lactulose (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (15 - 90 ml/day) for 24 weeks in Ltg
Trial: 12887812
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Cg) with no lactulose treatment
Trial: 1455377
Drug: Chondroprotective therapy;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroprotective therapy; specific drugs not mentioned; details on dosage and duration not available.
Trial: 1455377
Drug: Chondroprotective drugs;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroprotective drugs; specific drugs not mentioned; details on dosage and duration not available.
Trial: 26433782
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of cadazolid twice daily for 10 days
Trial: 26433782
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of cadazolid twice daily for 10 days
Trial: 26433782
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of cadazolid twice daily for 10 days
Trial: 25534724
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg of vancomycin four times daily for 10 days
Trial: 26433782
Drug: All cadazolid
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All cadazolid doses
Trial: 15225946
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg
Trial: 10726353
Drug: Zoladex (GnRH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoladex (GnRH agonist)
Trial: 12542601
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (without medication)
Trial: 7562288
Drug: Amoxicillin prophylaxis
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin prophylaxis (100 mg/kg per day)
Trial: 7562288
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no prophylactic antibiotic treatment)
Trial: 2265368
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 mg IV followed by infusion of 20 mg in 400 ml of 5% glucose)
Trial: 2265368
Drug: Placebo (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (400 ml of 5% glucose)
Trial: 7005459
Drug: 4-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-day course of doxycycline therapy
Trial: 7005459
Drug: 10-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day course of doxycycline therapy
Trial: 30670270
Drug: Bikram yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bikram yoga intervention (3-5 classes weekly for 16 weeks)
Trial: 18690916
Drug: Benzodiazepine hypnotics
RxNorm normalized name: 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
DrugBank: Nitrazepam (DB01595)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzodiazepine hypnotics (recommended dose)
Trial: 18690916
Drug: Benzodiazepine hypnotics
RxNorm normalized name: 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
DrugBank: Nitrazepam (DB01595)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzodiazepine hypnotics (twice the recommended dose)
Trial: 18690916
Drug: Zaleplon (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zaleplon (10 and 20 mg)
Trial: 14680731
Drug: Short-term enoxaparin
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term enoxaparin 1 mg/kg subcutaneously twice a day
Trial: 14680731
Drug: Short-term unfractionated
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term unfractionated heparin (UFH)
Trial: 14680731
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of a fixed-dose enoxaparin 60 mg subcutaneously twice a day
Trial: 2768695
Drug: Fluoride-free placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride-free placebo gel
Trial: 16707912
Drug: No insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No insulin
Trial: 20687400
Drug: No metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No metformin
Trial: 25975659
Drug: Uninterrupted rivaroxaban
RxNorm normalized name: Rivaroxaban
DrugBank: Rivaroxaban (DB06228)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Uninterrupted rivaroxaban (20 mg once-daily)
Trial: 24219882
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (transdermal estradiol 1 mg/d, oral estradiol 2 mg/d with or without medroxyprogesterone acetate 5 mg/d)
Trial: 23006063
Drug: Profiling group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Profiling group (dialysate temperature 35.5°C, variable sodium concentration [150-138 mEq/L], variable UF rate)
Trial: 23006063
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (dialysate temperature 37.0°C, fixed sodium concentration [138 mEq/L], fixed UF rate)